Listen: VC malaise, FDA confusion, & yet another Alzheimer’s debate
Is the era of the unicorn over? What’s gotten into the FDA? And will a…
Category: The Readout LOUD
Listen: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines
How do you stop a Covid surge? Why are clinical trials so white? And what…
Listen: Juul’s doomsday, Merck’s buyout plans, & the next Theranos verdict
Just how powerful is the FDA? Is Merck about to spend $40 billion? And what’s…
STAT+: A longtime investor talks interest rates, biotech, and why luxury cars are a warning sign
This week the central bank hiked interest rates by three quarters of a percentage point,…
Listen: Paul Offit on Covid vaccines for kids, plus: how the Fed affects biotech, & another Alzheimer’s setback
Will biotech stocks ever recover? How well do Covid-19 vaccines work for kids? And can…
Listen: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
When is data “practice-changing”? How many Covid-19 vaccines do we need? And what does it…
STAT+: Strategist Jared Holt on why innovation may not be such a good thing for the biotech sector
Every year, the meeting of the American Society of Clinical Oncology, or ASCO, is one…
Listen: Biotech’s catch-22, a $100 genome, & dealing with monkeypox
Will gene therapy ever live up to expectations? Can anyone break up the genomics monopoly?…
An emergency doctor and parent sorts through Covid vaccine options for kids under 5
After months of delays and setbacks, there finally appears to be hope that there will…
Listen: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
Covid vaccines for the youngest kids are up for review, but which jab — Moderna…
Listen: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
What happens when the White House runs out of Covid-19 money? Why are kids suddenly…
Listen: A CEO’s arrest, Pfizer’s big deal, & Covid on the rise
Is the next Covid surge upon us? How do you make $350,000 a day in…
.jpg)
Listen: Succession at Biogen, surprises at Vertex, & a potential superspreader dinner
Who’s going to run Biogen? Does Aduhelm have a future? And is it OK to…
Listen: How cancer-killing cell therapies work, biotech’s endless downturn, & an FDA conundrum
Can rewired cells cure some patients’ cancer? Do biotech stocks ever go up? And why’s…
Listen: An ominous biotech deal, vaccines for kids, & ‘breakthrough’ devices
Can buyouts be bad news? Why can’t Novavax meet a deadline? And what does “breakthrough”…
Leana Wen talks Covid risk tolerance and her response to critics
When at least 80 out of about 600 people who attended the swanky Gridiron Club…
.jpg)
Listen: Leana Wen on the pandemic’s new normal and whether Twitter is real life
Are we supposed to just get used to superspreader events? What’s going with Editas Medicine?…
Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success
What’s on tap for Roche and its closely followed cancer immunotherapy? Are we all headed…
Listen: Helen Branswell on the evolving pandemic, plus the next FDA debate and the perks of being a CEO
Are Covid-19 vaccines a sustainable business? Was Aduhelm an aberration? And what comes after Omicron?…
Listen: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas
How should pharma treat Russia? Why can’t Congress pass a drug pricing bill? And what…
Listen: Gilead’s growing pains, Covid’s origins, & Theranos as prestige TV
Can biotech companies age gracefully? Where did Covid-19 come from? And does Theranos make for…
Listen: Biden’s plans for Covid pills, the latest vaccine data, & fighting about CRISPR
Is “test to treat” too good to be true? Does it really matter who gets…
Listen: Medical racism, new Covid vaccines, & the resilience of Regeneron
How many Covid-19 vaccines does the world really need? What will it take to address…
Listen: Biotech in 2022, the Omicron surge, & the Elizabeth Holmes verdict
How worrisome is Omicron? Are the vibes off in biotech? And does the Theranos verdict…
Listen: Covid in 2022, J.P. Morgan bows to pressure, & the year in review
Will we be getting boosters forever? Does Jamie Dimon hate Zoom? And how do you…
Listen: Biogen, Biogen, Biogen, with a dash of Omicron
How did the Aduhelm debacle push Biogen to the brink? And what’s the latest on…
Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron
Will the first Covid-19 pill be all that useful? How worrisome is Omicron? And when…
Listen: Biogen’s scientific succession & Michael Osterholm on pandemic Thanksgiving
Are we in for another winter surge? Has Biogen bottomed out? And can Covid-19 pills…
Listen: Moderna v. NIH, psilocybin as a medicine, & the cultural intake of pharma CEOs
Who invented Moderna’s Covid-19 vaccine? Can psychedelic medicines be mainstream? And who’s going to run…
STAT+: John Maraganore on what comes next for Alnylam and his career
This interview is an excerpt from a recent segment on “The Readout LOUD.” Listen to…
Listen: Moderna’s setback, the saga of drug pricing reform & a CEO’s next act
Is drug pricing reform actually happening? Why was Moderna’s stock down? And what’s next for…
Listen: Vaccines for kids, inside Operation Warp Speed, & a big biotech resignation
Can the FDA be too transparent? Who deserves credit for Operation Warp Speed? And when…
Listen: Inside the vaccine race, how a Covid pill failed, & Biogen’s troubled launch
Is Moderna misunderstood? Can Biogen turn a profit in Alzheimer’s disease? And what went wrong…
Listen: The FDA star search, more booster debates, & the future of mRNA
Are we any closer to getting a permanent FDA boss? How many Covid-19 vaccinations does…
Listen: Shkreli on film, the next NIH director, and a looming FDA deadline
Did we learn anything from the Martin Shkreli saga? Who will run the NIH? And…
Listen: Health equity ‘tourism,’ an $11B biopharma acquisition, & a bony Covid protest
An $11 billion biopharma acquisition. Health equity “tourism.” And, where can you buy a 12-foot…
Scott Gottlieb on Covid, a better CDC, and how he does it all
Former FDA commissioner Scott Gottlieb can now add published author to his long list of…
Listen: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm’s slow rollout
What does Covid-19 have in store for this winter? Is Aduhelm a commercial dud? And…
Listen: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial
Can prosthetic limbs feel real? Is the FDA softening under pressure? And are Rice Krispies…
Listen: Verily’s moment of truth, Aduhelm’s rocky rollout, & the problem with Covid testing
Are we ever getting that Tricorder? Why’s it so hard to find Covid-19 tests? And…
Listen: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals
Does the Theranos trial actually matter? Is the FDA coming unglued? And what can prescription…
Listen: Vaccine mandates, biotech’s messy summer, & a pharmaceutical thriller
What’s standing in the way of mandatory Covid-19 vaccination? Is biotech in a credibility crisis?…
Listen: Biotech’s trust issues, overwhelmed health workers, & the nuances of insider trading
Why is the FDA so shy about rejection? How are health workers holding up in…
Listen: Biden’s drug pricing plan, Wall Street’s Alzheimer’s fixation, & daily 5 a.m. alarms
Can drug pricing help Democrats keep the Senate? Why is there still no nominee for…
Listen: The mRNA gold rush, Delta’s alarming rise, & the next treatment for Alzheimer’s
Who’s going to win the mRNA bake-off? How worrisome is the Delta variant? And why…
Listen: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen
How long do vaccines last? Is the microbiome overhyped? And who should play Jennifer Doudna…
How concerned should we be about breakthrough coronavirus infections? One expert weighs in
In the past week, you may have heard about Olympic athletes who are fully vaccinated…
Listen: Breakthrough infections, the power of lobbying, & pharma’s cinematic villainy
Did we take off our masks too soon? Can Democrats pass a drug pricing bill?…
Listen: The FDA’s future, Biden’s tight ship, & the latest Aduhelm twist
Who’s going to run the FDA? Why isn’t the Biden administration leakier? And what if…
Listen: Aduhelm’s latest twist, how Covid variants are shaping the summer, & a digital health boom
How worrying is the Delta variant? Is there a digital health bubble? And what is…